Schools and Pediatricians Will Be Key to Biden ’s Childhood Vaccine Rollout

The White House outlined its COVID-19 plan to vaccinate younger children which would focus on smaller doses administered with smaller needles if the shots are authorized by regulators. “We will be ready to get shots in arms,” President Joe Biden’s COVID-19 response coordinator, Jeff Zients, said Wednesday during a White House briefing on the plan, which includes supporting vaccination by primary care doctors and in pharmacies and schools. The U.S. has ordered enough supply to vaccinate all kids 5 to 11, the White House said in a statement Wednesday. The vaccination campaign for kids would differ from the one targeting adults and children 12 and older in that it will enlist pediatricians to work with parents, rather than utilizing mass inoculation sites. The vials and needles used to administer doses also will be smaller, the White House said. [time-brightcove not-tgx=”true”] The shots will be available at more than 25,000 doctors’ offices and primary care sites, as well as children’s hospitals and pharmacies. “The administration will work with states and local partners to make vaccination sites available at schools and other trusted community-based sites across the country,” according to the White House statement. The doses, which are one-third the strength of the regular dose given to those 12 and up, will be shipped in smaller configurations more easily stored at a typical pediatrician’s office, the White House sai...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

Related Links:

Jeffrey A. SingerPolitical polarization hinders progress against the COVID-19 pandemic.Political polarization may explain why, after former President Trump called the off ‐​label use of the anti‐​malarial drug hydroxychloroquine a “game‐​changer” in the battle against COVID-19 (randomized controlled trials found that isnot the case), public health officials and the mainstream press appear uninterested in the off ‐​label use of any other drugs as therapeutics against a COVID infection.For example, impressive data from randomized controlled trials show the off ‐​label use of the off‐​...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
Really, there's just no other word for it. You may have seen this tweet from Republican representative Marjorie Taylor Green -- and keep in mind that she got a huge majority of votes in her district. And oh yeah, this already had nearly 4,000 likes when snipped. If I have to explain to you why this is stupider than an 80 pound bag of portland cement, there is no hope for you. Then there is Senator Ron Johnson, who won the majority of votes in the entire state of Wisconsin,who accuses Anthony Fauci of  " overhyping " the AIDS epidemic.Discussing the omicron variant, Johnson accused individuals in the U.S...
Source: Stayin' Alive - Category: American Health Source Type: blogs
Sarah Gilbert helped develop the Oxford-AstraZeneca COVID-19 vaccine. She says without more spending to fight emerging viral threats, the next pandemic could be more contagious and more lethal.(Image credit: Steve Parsons/AP)
Source: NPR Health and Science - Category: Consumer Health News Authors: Source Type: news
The Republic of Congo received just over 300,000 doses of the COVID vaccines through the COVAX Facility in August 2021. The international COVAX initiative aimed at guaranteeing global access to the vaccines, recently announced that it was being forced to slash planned deliveries to Africa, by around 150 million doses this year. The scheme is now expected to deliver 470 million doses through the end of December. These will be enough to protect just 17 per cent of the continent, far below the 40 per cent target, according to the World Health Organization (WHO). Credit: UNICEF/Aimable TwiringiyimaBy Victoria Fan and Steve Kuo...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Africa COVID-19 COVID-19 VACCINES Development & Aid Economy & Trade Featured Financial Crisis Headlines Health TerraViva United Nations Trade & Investment IPS UN Bureau Source Type: news
One of the scientists behind the Oxford-AstraZeneca Covid-19 vaccine on Monday warned that the next pandemic could be even more deadly than the current one. #vaccinecocreator #astrazeneca
Source: Reuters: Health - Category: Consumer Health News Source Type: news
Clin Ther. 2021 Nov 16:S0149-2918(21)00457-4. doi: 10.1016/j.clinthera.2021.11.003. Online ahead of print.ABSTRACTPURPOSE: The goal of this study was to assess if caregivers' attitudes toward the regulatory process of approving the vaccine against coronavirus disease 2019 (COVID-19) for children aged
Source: Clinical Therapeutics - Category: Drugs & Pharmacology Authors: Source Type: research
Curr Res Pharmacol Drug Discov. 2021;2:100062. doi: 10.1016/j.crphar.2021.100062. Epub 2021 Oct 5.ABSTRACTCOVID-19 is an infectious disease that affects the respiratory system and is caused by the novel coronavirus SARS-CoV-2. It was first reported in Wuhan, China, on December 31, 2019, and has affected the entire world. This pandemic has caused serious health, economic and social problems. In this situation, the only solution to combat COVID-19 is to accelerate the development of antiviral drugs and vaccines to mitigate the virus and develop better antiviral methods and excellent diagnostic and prevention techniques. With...
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research
DISCUSSION: Pacific Eclipse illustrated the impact of a pandemic of smallpox under different response scenarios, which were validated to some extent by the COVID-19 pandemic. The framework developed from the scenario draws out modifiable determinants of pandemic severity which can inform pandemic planning for the ongoing COVID-19 pandemic and for future pandemics.PMID:34865873 | DOI:10.1016/j.vaccine.2021.10.081
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
This second pandemic year affirmed the drug industry's strength in tackling public health crises. Headlines in 2021 were dominated by the arrival of COVID-19 vaccines and, recently, antiviral treatments, but pharmaceutical and biotech companies also continued to work on new technologies that could transform care for people with other diseases.
Source: Chemical and Engineering News - Category: Chemistry Source Type: research
This second pandemic year affirmed the drug industry's strength in tackling public health crises. Headlines in 2021 were dominated by the arrival of COVID-19 vaccines and, recently, antiviral treatments, but pharmaceutical and biotech companies also continued to work on new technologies that could transform care for people with other diseases.
Source: Chemical and Engineering News - Category: Chemistry Source Type: research
More News: Afghanistan Health | Children | COVID-19 | Department of Health | Education | Food and Drug Administration (FDA) | Health | Hospitals | International Medicine & Public Health | Pandemics | Pediatrics | Pfizer | Politics | Primary Care | Universities & Medical Training | Vaccines